CA Patent

CA2645080A1 — Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same

Assigned to Novavax Inc · Expires 2007-09-13 · 19y expired

What this patent protects

The present invention provides a new tri-phasic method for making nanoparticles of poorly soluble active pharmaceutical ingredients

USPTO Abstract

The present invention provides a new tri-phasic method for making nanoparticles of poorly soluble active pharmaceutical ingredients

Drugs covered by this patent

Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)

Patent Metadata

Patent number: CA2645080A1
Jurisdiction: CA
Classification: —
Expires: 2007-09-13
Drug substance claim: No
Drug product claim: No
Assignee: Novavax Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.